Real-time enrollment status for this prostate cancer clinical trial
Current Status
Recruiting
Checked: August 29, 2026 at 12:53 AM UTC
| NCT Number | NCT07028853 |
| Recruiting Status | Recruiting |
| Condition | Prostate Cancer |
| Phase | PHASE3 |
| Target Enrollment | 1,000 participants |
| Active Locations | 124 sites in the US |
| Sponsor | Pfizer |
| Last Updated on CT.gov | August 14, 2026 (2 weeks ago) |
As of August 29, 2026: Clinical trial NCT07028853 is currently recruiting participants. This phase3 study for prostate cancer is actively seeking new participants at 124 locations across the United States. The study is sponsored by Pfizer. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07028853 is actively recruiting participants as of August 29, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 124 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07028853 was last updated 2 weeks ago (August 14, 2026). HelloStudys verifies this status automatically.